What type of study is this?

This is a Cohort Study study (also classified as: Animal Study).

October 1, 2025

[iPS cell-based therapy for muscular disorders].

View Full Paper

Ask AI

Bookmark

Cell transplantation from iPSCs improved regeneration of dystrophin-positive fibers in DMD model mice.
Over 10% of dystrophin-positive fibers were regenerated, enhancing muscle function and fatigue tolerance.
iPSC-derived mesenchymal stromal cells restored collagen type VI in UCMD model mice, promoting muscle health.
Somatic MSCs were ineffective in treatment despite collagen type VI restoration, highlighting the unique properties of iMSCs.

No takes yet. Share an insight, caveat, or question.

This research demonstrates effective cell transplantation using iPSCs for Duchenne muscular dystrophy and Ullrich congenital muscular dystrophy.

Hidetoshi Sakurai (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This research demonstrates effective cell transplantation using iPSCs for Duchenne muscular dystrophy and Ullrich congenital muscular dystrophy.